Registry for collecting oncology patient data
Official title: A Prospective Registry for Collecting Standardized, Routine Care Data to Characterize Patients, Treatment Patterns, Safety and Treatment Effectiveness in Adult Oncology Patients
Run by N-Power Medicine · NCT06877884 · Data updated 2026-11-12
This study is collecting information from cancer patients to help improve research and make it easier for them to join clinical trials.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 120 Years |
| Sex | All |
| Enrollment | 20000 (estimated) |
| Sponsor | N-Power Medicine Industry-sponsored |
| Locations | 7 sites (Monterey, California and 6 other locations) |
| Status | Recruiting |
| Started | August 1, 2022 |
| Main results expected | January 2099 |
| Study ends | January 2099 |
| Registry record updated | October 20, 2025 |
| Trial ID | NCT06877884 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adult patients (18 years and older) receiving care at participating oncology centers who can provide informed consent.
✕Probably not a fit
Patients who are prisoners or unable to consent without a legally authorized representative may not benefit from this registry.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational registry collects standardized data from patients at various oncology centers. It includes information on baseline variables, treatments administered, and patient-reported outcomes through surveys. The goal is to create a comprehensive database that can facilitate patient participation in clinical trials and enhance research and development in oncology.
Why it matters
Potential benefit: If successful, this registry could improve the understanding of cancer treatments and outcomes, leading to better patient care and more effective clinical trials.
How similar studies have gone: Other observational registries in oncology have shown success in improving data collection and patient engagement, making this approach promising.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Be a patient at a site (oncology) participating in the Registry Be at least 18 years old Be able and willing to provide signed informed consent Exclusion Criteria: Prisoners/imprisonment at time of screening for eligibility Patients who cannot consent without utilization of a legally authorized representative
Where it's running
-
Pacific Cancer Care
Monterey, California, United States Recruiting -
Bayhealth Cancer Center-Kent
Dover, Delaware, United States Recruiting -
Bayhealth Cancer Center- Sussex
Milford, Delaware, United States Recruiting -
Northwest Oncology & Hematology
Elk Grove Village, Illinois, United States Recruiting -
New Mexico Oncology Hematology Consultants
Albuquerque, New Mexico, United States Recruiting -
Lankenau Medical Center
Paoli, Pennsylvania, United States Recruiting
Show 1 more location
-
Oncology Consultants, P.A.
Houston, Texas, United States Recruiting
Study contacts
- Study coordinator: Christer Svedman, MD
- Email: support@npowermedicine.com
- Phone: 833-467-6734
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
External control arm registry for non-small cell lung cancer
This project will build control groups from current and future clinical and registry data to help compare treatments for adults with non-small cell lung cancer.
-
Prospective external control cohort for newly diagnosed advanced EGFR‑mutant NSCLC
This project will create a prospective group of people with newly diagnosed advanced EGFR‑mutant non‑small cell lung cancer to collect standardized clinical and imaging data as an external control for treatment comparisons.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.